These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10504869)

  • 21. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tuberculosis programs in Thailand: a cost analysis.
    Chunhaswasdikul B; Kamolratanakul P; Jittinandana A; Tangcharoensathien V; Kuptawintu S; Pantumabamrung P
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):195-9. PubMed ID: 1439970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evolution of the treatment of tuberculosis].
    Grassi C
    Minerva Med; 1984 Mar; 75(11):569-72. PubMed ID: 6709194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for TB.
    AIDS Action; 1996 Feb; (31):8-9. PubMed ID: 12320027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis in the intensive care unit: a chemotherapeutic controversy.
    Fields CL; Roy TM; Ossorio MA; Mercer PJ; Anderson WH
    J Ky Med Assoc; 1991 Oct; 89(10):502-6. PubMed ID: 1744512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do private doctors follow national guidelines for managing pulmonary tuberculosis in Pakistan?
    Shah SK; Sadiq H; Khalil M; Noor A; Rasheed G; Shah SM; Ahmad N
    East Mediterr Health J; 2003 Jul; 9(4):776-88. PubMed ID: 15748074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent tuberculosis: definitions and treatment regimens.
    Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):851-4. PubMed ID: 10524580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Respiratory tuberculosis in Seine-Saint-Denis. Results of treatment].
    Lepetit C; Thebaud-Mony A
    Rev Mal Respir; 1989; 6(5):451-6. PubMed ID: 2602618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of extra-pulmonary tuberculosis.
    Drug Ther Bull; 1991 Apr; 29(7):26-8. PubMed ID: 1935605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the Revised National Tuberculosis Programme.
    Jhunjhunwala B
    Health Millions; 1995; 21(1):29-33. PubMed ID: 12288993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu; Chukanov VI; Vylegzhanin SV
    Probl Tuberk; 2001; (7):13-8. PubMed ID: 11763553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.